Navigation Links
BIT Group Restructure Will Consolidate California Facilities to Form BIT USA Inc.
Date:7/22/2013

San Diego, CA (PRWEB) July 22, 2013

BIT Group has announced that this October, the company will unveil a new global executive management restructuring initiative focused on continuous improvement of USA operations while the company continues to grow worldwide. One of the most visible changes will be the consolidation of BIT Group’s two California facilities to form BIT USA Inc. Following a five- year transition of ownership, Source Scientific of Irvine, CA became a wholly-owned BIT Group company in January, 2013. BIT MedTech (formerly California MedTech) was acquired by BIT Group in August, 2011.

The new executive team will be led by BIT Group CEO, Marius Balger, who is currently responsible for BIT Group worldwide; under the new structure, Balger will also serve as CEO of BIT USA. “The USA is an extremely important market for BIT Group,” revealed Balger. “In addition to creating BIT USA Inc. – which will capitalize on economies of scale and offer more customized services to our US customers – we are restructuring our management so as to better focus on our U.S. growth. With a broader presence in the USA, we can offer U.S. customers many BIT Group synergies, such as BIT platform solutions to accelerate products’ time-to-market or a skilled global R&D team to assist with localized projects.”

Other members of the BIT Group executive team include Gotthard von Falkenhausen as Global CFO, and Global COO, Thomas Eck , who, in addition to his executive tasks in Schwalbach, Germany, will oversee BIT Group‘s fast-growing business operations worldwide.

BIT Group provides contract product development, manufacturing and after-sales service for life science research, medical and IVD instrumentation. Quality standards include GMP, FDA registered, ISO13485 & 9001, QSR, Class I, II, and III. BIT global operations in USA, Germany, France, China & Japan deliver precision engineered, cost effective systems solutions. Pre-engineered BIT SMARTSOLUTIONS™ platform technologies reduce development cost and time-to-market; lean manufacturing centers and global supply chain enable competitive product cost.

Read the full story at http://www.prweb.com/releases/2013/7/prweb10949137.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Novel study using new technologies outlines importance of California condor social groups
2. Biotech Investment Group Launches Formex, LLC
3. BioTech Companies in the News - Alliqua, Transition Therapeutics, Organovo, MiMedx Group, Keryx Biopharmaceuticals
4. World Hematology & Flow Cytometry Market Reviewed in New Venture Planning Group DataPack Available at MarketPublishers.com
5. OTC Markets Group Congratulates Organovo Holdings on Move to NYSE MKT
6. KJT Group Hires Director of Health Outcomes
7. Smart Consulting Group and The Catalyst Group Form Alliance to Supply Quality Compliance Consulting Services For the Pharmaceutical Industry
8. Knowledgent Group Inc. Applies for Patent in Chemical Information Management
9. Cellular Biomedicine Group Announces Expansion in the Osteoarthritis and Rheumatoid Arthritis Market
10. Cellular Biomedicine Group Announces Appointment of Corporate Controller
11. CTI Reports Final Results from Cooperative Group and NCI-Sponsored Trial of Brostallicin in Patients with Metastatic Triple-Negative Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... Pharmaceuticals, Inc. ("InMed") (CSE: IN; OTCQB: IMLFF), reported today that ... total of 10,672,750 common share purchase warrants have been exercised ... the exercise of these warrants totalled $1,387,458 and 10,672,750 common ... ... expression of confidence by our warrant holders. This infusion of ...
(Date:2/27/2017)... , Feb. 27, 2017 Fluxion Biosciences ... Spain has been appointed as a Certified ... The IsoFlux system will be used in Genetracer Biotech,s ... to lung and colon cancer, with plans to move ... laboratory is utilizing Fluxion,s IsoFlux System to isolate, recover, ...
(Date:2/25/2017)... (PRWEB) , ... February 25, 2017 , ... ... Verified Clinical Trials in an ongoing effort to create meaningful change ... advocacy, and pharmaceutical research with emphasis on consumers and patients’ mental health well-being. ...
(Date:2/24/2017)... 2017 Provectus Biopharmaceuticals, Inc. (OTCQB: PVCT, ... clinical-stage oncology and dermatology biopharmaceutical company, today is ... in its previously announced rights offering of up ... common stock and Series C Convertible Preferred Stock ... As previously announced, the rights ...
Breaking Biology Technology:
(Date:2/21/2017)... and PORTLAND, Ore. , Feb. ... the Avamere Family of Companies (Avamere Health Services, Infinity ... a six-month research study that will apply the power ... at senior living and health centers. By analyzing data ... to gain insights into physical and environmental conditions, and ...
(Date:2/13/2017)... , Feb. 13, 2017  RSA Conference -- RSA, ... that is designed to enhance fraud detection and ... in the RSA Fraud & Risk Intelligence Suite. ... to leverage additional insights from internal and external ... better protect their customers from targeted cybercrime attacks. ...
(Date:2/8/2017)... , Feb. 8, 2017 About Voice ... voice to match it against a stored voiceprint ... as pitch, cadence, and tone are compared to ... minimal hardware installation, as most PCs already have ... different transactions. Voice recognition biometrics are most likely ...
Breaking Biology News(10 mins):